# QZX: Positive Blood Culture Processor For Inoculum Preparation Used For Antimicrobial Susceptibility Testing

- Device class: 2; regulation: 21 CFR 866.1650; FDA's rule: 510(k) required
- FDA decisions: 3
- 510(k) review time 2021–2025: median 254 days (middle half 171–353)
- Recalls: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 2024: 2
- 2025: 1

## Most-cited predicates
- K231536: eQUANT System (2024), cited by 1
- K223493: PBC Separator with Selux AST System (2024), cited by 1

Source page: https://510kreport.com/product-code/QZX
Data by year (CSV): https://510kreport.com/product-code/QZX.csv
